Cómo tratar la hiperglucemia durante la internación | 15 DIC 17

Insulinoterapia en situaciones especiales

La hiperglucemia durante la internación es una condición frecuente que se asocia al aumento de complicaciones y resulta en un mal pronóstico para quienes la padecen. La estrategia para su tratamiento es la insulinoterapia
INDICE:  1. Página 1 | 2. Página 1
Página 1

1.  Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hos- pitalizations for patients with diabetes. Diabetes Care 2003; 26: 1421-6.

2.  Donnan PT, Leese GP, Morris AD, et al. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. Diabetes Care 2000; 23: 1774-9.

3.  Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in- hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-82.

4.  Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health ex- amination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378: 31-40.

5.  Kosiborod M, Inzucchi S, Spertus J, et al. Elevated admis- sion glucose and mortality in elderly patients hospitalized with heart failure. Circulation 2009; 119: 1899-907.

6.  Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010; 8: 29.

7.  Van Den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-67.

8.  Umpierrez G, Hellman R, Korytkowski M, et al. Manage- ment of hyperglycemia in hospitalized patients in non- critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 16-38.

9.  Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest 2007; 117: 868-70.

10.  Mc Donell ME, Umpierrez GE. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metabol Clin North Am 2012; 41: 175-201.

11.  Qaseem A, Humphrey L, Chou R, et al. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011; 154: 260-7.

12.  Moghissi ES, Korytkowski M, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32: 1119-31.

13.  Kitabchi AE, Umpierrez GE, Murphy MB, et al. Manage- ment of hyperglycemic crises in patients with diabetes. Diabetes Care 2001; 24: 131-53.

14.  Boden G. Gluconeogenesis and glycogenolysis in health and diabetes. J Investig Med 2004; 52: 375-8.

15.  Umpierrez GE, Pasquel FJ. Management of inpatient hyperglycemia and diabetes in older adults. Diabetes Care 2017; 40: 509-17.

16.  Greci LS, Kailasam M, Malkani S, et al. Utility of HbA levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 2003; 26: 1064-8.

17.  Mazurek JA, Hailpern SM, Goring T, Nordin C. Prevalence of hemoglobin A1c greater than 6.5% and 7% among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital. J Clin Endocrinol Metab 2010; 95: 1344-8.

18.  Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125: 1007-21.

19.  Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67: 352-60.

20.  Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-61.

21.  Brunkhorst FM, Bloos EC, Meier-Hellmann A, et al. In- tensive insulin therapy and pentastarch resuscitation in severe sepsis; N Engl J Med 2008; 358: 125-39.

22.  Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009; 35: 1738-48.

23.  The NICE Sugar Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-97.

24.  Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple and effective in 120,618 hours of opera- tion. Diabetes Care 2005; 28: 2418-23.

25.  Carreño Hernández MC, Sabán Ruiz J, Fernández Ballesteros A, et al. Manejo del paciente diabético hospitaliza- do. An Med Intern (Madrid) 2005; 22: 339-48.

26.  Hor TK, Smiley D, Munoz C, et al. Comparison of inpa- tient insulin regimens: detemir plus aspart vs. NPH plus regular in medical patients with type 2 diabetes (DEAN Trial). Diabetes 2008 57: A137.

27.  Umpierrez GE, Smiley D, Hermayer K, et al. Randomized study comparing a basal-bolus with a basal-plus cor- rection insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care 2013; 36: 2169-74.

28.  Hirsch IB. Insulin analogues. N Engl J Med 2005; 352: 174-83.

29.  Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient man- agement of patients with type 2 diabetes (RABBIT 2 Trial). Diabetes Care 2007; 30: 2181-6.

30.  Inzucchi SE. Clinical practice. Management of hypergly- cemia in the hospital setting. N Engl J Med 2006; 355: 1903-11.

31.  Handelsman Y, Mechanick JL, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guide- lines for Clinical Practice for developing a diabetes mel- litus comprehensive care plan. Endocr Pract 2011; 17 Suppl 2: 1-53.

32.  Bailey RA, Wang Y, Zhu V, Rupnow MF. Chronic kidney disease in US adults with type 2 diabetes: an updated na- tional estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Res Notes 2014; 7: 415.

33.  Marinovich S, Lavorato C, Bisigniano L, et al. Registro Ar- gentino de Diálisis Crónica 2013 Informe 2014. Instituto Nacional Central Único Coordinador de Ablación e Implan- te (INCUCAI). Sociedad Argentina de Nefrología (SAN) Base de datos, 2014, vol. 18. En: http://www.incucai.gov. ar/files/docs-incucai/Materiales/informes-estadisticos/17- REGISTRO_ARGENTINO_DE_DIALISIS_2013_VER- SION_COMPLETA.pdf;  consultado el 18/04/2017.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024